X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
ADCOCK INGRAM
Jun-14
UNICHEM LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs382365-   
Low Rs234264-   
Sales per share (Unadj.) Rs116.3108.7-  
Earnings per share (Unadj.) Rs-18.9-27.4-  
Cash flow per share (Unadj.) Rs-11.7-22.7-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.085.3-  
Shares outstanding (eoy) m70.34168.78-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.62.9 91.6%   
Avg P/E ratio x-16.3-11.5 141.8%  
P/CF ratio (eoy) x-26.2-13.9 189.4%  
Price / Book Value ratio x0.83.7 21.9%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,66853,081 40.8%   
No. of employees `0002.34.3 53.1%   
Total wages/salary Rs m2,0063,331 60.2%   
Avg. sales/employee Rs Th3,587.84,273.4 84.0%   
Avg. wages/employee Rs Th880.0776.0 113.4%   
Avg. net profit/employee Rs Th-583.7-1,076.8 54.2%   
INCOME DATA
Net Sales Rs m8,18018,346 44.6%  
Other income Rs m610128 474.9%   
Total revenues Rs m8,79018,474 47.6%   
Gross profit Rs m-1,320-3,179 41.5%  
Depreciation Rs m505792 63.8%   
Interest Rs m80497 16.1%   
Profit before tax Rs m-1,295-4,339 29.8%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m33271 12.3%   
Profit after tax Rs m-1,331-4,623 28.8%  
Gross profit margin %-16.1-17.3 93.1%  
Effective tax rate %-2.6-6.2 41.3%   
Net profit margin %-16.3-25.2 64.6%  
BALANCE SHEET DATA
Current assets Rs m23,31813,437 173.5%   
Current liabilities Rs m4,6357,560 61.3%   
Net working cap to sales %228.432.0 713.0%  
Current ratio x5.01.8 283.0%  
Inventory Days Days122111 109.8%  
Debtors Days Days121124 98.0%  
Net fixed assets Rs m8,1637,832 104.2%   
Share capital Rs m14185 165.2%   
"Free" reserves Rs m26,6600-   
Net worth Rs m26,80114,399 186.1%   
Long term debt Rs m35,060 0.1%   
Total assets Rs m31,89027,201 117.2%  
Interest coverage x-15.2-7.7 196.2%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.30.7 38.0%   
Return on assets %-3.9-15.2 25.9%  
Return on equity %-5.0-32.1 15.5%  
Return on capital %-4.5-19.8 22.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,3560-   
CASH FLOW
From Operations Rs m-1,1231,566 -71.7%  
From Investments Rs m16,487-481 -3,428.9%  
From Financial Activity Rs m-8,8114,592 -191.9%  
Net Cashflow Rs m6,5525,678 115.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.04 Rs / ZAR

Compare UNICHEM LAB With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: DR. DATSONS LABS  SUVEN LIFE  PANACEA BIOTECH  VENUS REMEDIES  BIOCON LTD  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views On News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 15, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS